<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="45510">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02513797</url>
  </required_header>
  <id_info>
    <org_study_id>RS-011</org_study_id>
    <nct_id>NCT02513797</nct_id>
    <nct_alias>NCT02631915</nct_alias>
  </id_info>
  <brief_title>aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation</brief_title>
  <acronym>aMAZE</acronym>
  <official_title>LEFT ATRIAL APPENDAGE LIGATION WITH THE LARIAT+® SUTURE DELIVERY SYSTEM AS ADJUNCTIVE THERAPY TO PULMONARY VEIN ISOLATION FOR PERSISTENT OR LONGSTANDING PERSISTENT ATRIAL FIBRILLATION</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SentreHEART, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SentreHEART, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective, multicenter, randomized (2:1) controlled study to evaluate the
      safety and effectiveness of the LARIAT System to percutaneously isolate and ligate the Left
      Atrial Appendage from the left atrium as an adjunct to planned pulmonary vein isolation
      (PVI) catheter ablation in the treatment of subjects with symptomatic persistent or
      longstanding persistent atrial fibrillation.

      This study will be conducted in two stages:

        -  Limited Early Stage (Stage 1): up to 175 subjects at up to 50 sites

        -  Pivotal Stage (Stage 2): up to 600 subjects at up to 50 sites All patients from both
           stages will be included in the primary analysis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Freedom from episodes of atrial fibrillation &gt; 30 seconds at 12 months post pulmonary vein isolation</measure>
    <time_frame>12 months following Pulmonary Vein Isolation catheter ablation procedure</time_frame>
    <description>Measured by 24-hour Holter Monitoring</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Freedom from any atrial fibrillation/atrial tachycardia/atrial flutter recurrence defined as any episode &gt; 30 seconds with or without AAD</measure>
    <time_frame>Following the 90 day blanking period through 12 months post-index pulmonary vein isolation</time_frame>
    <description>Measured by 24-hour Holter Monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite endpoint of stroke of any cause and systemic embolism as adjudicated by the clinical events committee</measure>
    <time_frame>12 months following index pulmonary vein isolation</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>LARIAT Technical Success</measure>
    <time_frame>Immediately post-LARIAT ligation (acute) and at 12 months following index pulmonary vein isolation</time_frame>
    <description>Successful placement of the LARIAT System pre-tied suture around the left atrial appendage to achieve left atrial appendage ligation defined as ≤1 ± 1mm diameter residual communication w/ left atrium, as assessed by transesophageal echocardiography color doppler</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>LARIAT + PVI Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Percutaneously isolate and ligate the Left Atrial Appendage (LAA) from the left atrium (LA) with the LARIAT System prior to planned pulmonary vein isolation (PVI) catheter ablation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PVI Catheter Ablation Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Perform pulmonary vein isolation (PVI) catheter ablation procedure using a contact force sensing, irrigated radiofrequency catheter approved by FDA for the treatment of atrial fibrillation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LARIAT + PVI</intervention_name>
    <description>Left Atrial Appendage ligation with the LARIAT System initially performed followed by adjunctive pulmonary vein isolation catheter ablation in staged procedures</description>
    <arm_group_label>LARIAT + PVI Treatment Group</arm_group_label>
    <other_name>Left Atrial Appendage ligation + Pulmonary Vein Isolation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pulmonary Vein Isolation</intervention_name>
    <description>Perform pulmonary vein isolation (PVI) catheter ablation procedure using a contact force sensing, irrigated radiofrequency catheter approved by FDA for the treatment of atrial fibrillation.</description>
    <arm_group_label>LARIAT + PVI Treatment Group</arm_group_label>
    <arm_group_label>PVI Catheter Ablation Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Documented diagnosis of symptomatic persistent or longstanding persistent
             non-valvular atrial fibrillation

          -  Failed at least one Class I or III Antiarrythmic drug (AAD)

          -  Life expectancy ≥ 1 year;

          -  Willing and able to return to and comply with scheduled follow-up visits and tests;
             and

          -  Willing and able to provide written informed consent

        Exclusion Criteria:

          -  Prior procedure involving opening of the pericardium or entering the pericardial
             space (e.g., coronary artery bypass graft, heart transplantation, valve surgery)
             where adhesions are suspected;

          -  Prior epicardial or endocardial atrial fibrillation ablation procedure;

          -  LA diameter &gt; 6 cm as measured by computerized tomography;

          -  Documented embolic stroke, transient ischemic attach or suspected neurologic event
             within 3 months prior to the planned intervention;

          -  Currently exhibits New York Heart Association Class IV heart failure symptoms;

          -  Documented history of right heart failure specifically when right ventricle exceeds
             the left ventricular size;

          -  Documented history of myocardial infarction (MI) within 3 months prior to the planned
             study intervention;

          -  Documented history of unstable angina within 3 months prior to the planned study
             intervention;

          -  Documented symptomatic carotid disease, defined as &gt; 70% stenosis or &gt; 50% stenosis
             with symptoms;

          -  End Stage Renal Disease (ESRD) or documented history of renal replacement / dialysis;

          -  Current documented history of clinically significant liver disease which predisposes
             the subject to significant bleeding risk (clinically defined by the treating
             physician);

          -  Any history of thoracic radiation with the exception of localized radiation treatment
             for breast cancer;

          -  Current documented use of long-term treatment with corticoid steroids, not including
             use of inhaled steroids for respiratory diseases;

          -  Active pericarditis;

          -  Active endocarditis;

          -  Any documented history or autoimmune disease associated with pericarditis;

          -  Evidence of Pectus Excavatum (documented and clinically defined by the treating
             physician);

          -  Untreated severe scoliosis (documented and clinically defined by treating physician);

          -  Documented Left Ventricular Ejection Fraction (LVEF) &lt; 30% within 30 days prior to
             planned intervention;

          -  Documented presence of implanted congenital defect closure devices, (e.g., atrial
             septal defect, patent foramen ovale or ventricular septal defect device);

          -  Previously attempted occlusion of the left atrial appendage (by any surgical or
             percutaneous method);

          -  Body Mass Index (BMI) &gt; 40;

          -  Evidence of active Graves disease;

        Additional Exclusion Criteria: Based on Screening / Pre-procedure Imaging

        Subjects will also be excluded if they meet any of the following:

          -  Based on screening computed tomography angiography performed within 90 days prior to
             study intervention as confirmed by the core lab:

               -  Left atrial appendage morphology: Superior-posterior oriented left atrial
                  appendage (i.e. superior C shape), that has:

                    1. Left atrial appendage LARIAT-approach width ≥ 40 mm; or

                    2. Left atrial appendage distal apex extending posterior to the ostium of the
                       appendage.

               -  Left atrial appendage positioned behind the pulmonary artery; or

               -  All other left atrial morphology: Left atrial appendage LARIAT approach width &gt;
                  45 mm.

          -  Based on a peri-procedural imaging (transesophageal echocardiography) at time of
             LARIAT or catheter ablation) and confirmed by institution's designated LARIAT
             echocardiographer:

               -  Intracardiac thrombus; or

               -  Significant mitral valve stenosis (i.e., mitral valve stenosis &lt; 1.5cm2)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David J Wilber, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Loyola University Department of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dhanunjaya Lakkireddy, MD</last_name>
    <role>Study Chair</role>
    <affiliation>KU Medical Center, University of Kansas</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pamela P Simons, BS, RT</last_name>
    <phone>650-241-6011</phone>
    <email>psimons@sentreheart.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chrysbe Madayag</last_name>
    <phone>650-241-6024</phone>
    <email>cmadayag@sentreheart.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Arizona Arrhythmia Research Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie Raymond</last_name>
      <phone>602-456-2342</phone>
      <email>sraymond@azheartrhythm.com</email>
    </contact>
    <investigator>
      <last_name>Vijendra Swarup, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Scripps Clinic</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chelsea Butler</last_name>
      <phone>858-652-5538</phone>
      <email>Butler.Chelsea@scrippshealth.org</email>
    </contact>
    <investigator>
      <last_name>Douglas Gibson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Hunter</last_name>
      <phone>858-657-5323</phone>
      <email>J2hunter@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Jonathan Hsu, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Minor, RN</last_name>
      <phone>323-442-7983</phone>
      <email>Melissa.minor@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Rahul Doshi, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anjali Doshi</last_name>
      <phone>949-212-5662</phone>
      <email>Anjali.Doshi@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Nitish Badhwar, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Santa Barbara Cottage Hospital</name>
      <address>
        <city>Santa Barbara</city>
        <state>California</state>
        <zip>93103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Isaacs</last_name>
      <phone>805-569-7461</phone>
      <phone_ext>57461</phone_ext>
      <email>lisaacs@sbch.org</email>
    </contact>
    <investigator>
      <last_name>Brett Gidney, MD, FACC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bemen Habashi</last_name>
      <phone>203-737-3570</phone>
      <email>bemen.habashi@yale.edu</email>
    </contact>
    <investigator>
      <last_name>James Freeman, M.D. MPH MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent's HealthCare</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Joseph</last_name>
      <phone>904-308-6405</phone>
      <email>lisa.joseph@jaxhealth.com</email>
    </contact>
    <investigator>
      <last_name>Saumil Oza, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Athens Regional Cardiology</name>
      <address>
        <city>Athens</city>
        <state>Georgia</state>
        <zip>30606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alyssa Smith, RN</last_name>
      <phone>706-475-1828</phone>
      <email>alyssa.smith@athenshealth.org</email>
    </contact>
    <investigator>
      <last_name>Kent Nilsson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cynthia Barnes, RN, CCRC</last_name>
      <phone>678-843-6093</phone>
      <email>Cynthia.barnes@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Hoskins, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern University / Bluhm Cardiovascular Institute</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Carswell</last_name>
      <phone>312-926-7554</phone>
      <email>Amy.carswell@nm.org</email>
    </contact>
    <investigator>
      <last_name>Albert C. Lin, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Loyola University Center for Heart and Vascular Medicine</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Schoenecker</last_name>
      <phone>708-216-2646</phone>
      <email>nschoenecker@luc.edu</email>
    </contact>
    <investigator>
      <last_name>David Wilber, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advocate Christ Medical Center</name>
      <address>
        <city>Oak Lawn</city>
        <state>Illinois</state>
        <zip>60453</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Nellett, APN</last_name>
      <phone>708-684-4522</phone>
      <email>Michelle.Nellett@advocatehealth.com</email>
    </contact>
    <investigator>
      <last_name>William Spear, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern Medicine Central DuPage Hospital</name>
      <address>
        <city>Winfield</city>
        <state>Illinois</state>
        <zip>60190</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seema Jain</last_name>
      <phone>630-933-7581</phone>
      <email>seema.jain@nm.org</email>
    </contact>
    <investigator>
      <last_name>Todd Tomson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Iowa Heart Center</name>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <zip>50266</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cecily Decklever</last_name>
      <phone>515-633-3843</phone>
      <email>cdecklever@iowaheart.com</email>
    </contact>
    <investigator>
      <last_name>Troy Hounshell, D.O.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center Research Institute</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donita Atkins</last_name>
      <phone>816-651-1969</phone>
      <email>datkins2@kumc.edu</email>
    </contact>
    <investigator>
      <last_name>Dhanunjaya Lakkireddy, MD FACC FHRS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ochsner Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacey Davis</last_name>
      <phone>504-842-8476</phone>
      <email>sdavis@ochsner.org</email>
    </contact>
    <investigator>
      <last_name>Freddy M Abi-Samra, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Martucci</last_name>
      <phone>410-502-0517</phone>
      <email>mmill148@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Ronald Berger, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grace Ha</last_name>
      <phone>617-643-0456</phone>
      <email>GHA2@mgh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Moussa Mansour, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UP Health System- Marquette</name>
      <address>
        <city>Marquette</city>
        <state>Michigan</state>
        <zip>49855</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lori Piggott, R</last_name>
      <phone>906-225-7190</phone>
      <email>lori.piggott@mghs.org</email>
    </contact>
    <investigator>
      <last_name>Rudolph Evonich, III, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Morristown Medical Center</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Deborah Brunetti</last_name>
      <phone>973-971-5951</phone>
      <email>deborah.brunetti@atlantichealth.org</email>
    </contact>
    <investigator>
      <last_name>Timothy Mahoney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Valley Hospital</name>
      <address>
        <city>Ridgewood</city>
        <state>New Jersey</state>
        <zip>07450</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen O'Keefe</last_name>
      <phone>201-447-8453</phone>
      <email>kokeefe@valleyhealth.com</email>
    </contact>
    <investigator>
      <last_name>Daniel Musat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Suneet Mittal, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Albany Medical Center</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda O'Malley</last_name>
      <phone>518-292-6000</phone>
      <email>aomalley@capitalcardiology.com</email>
    </contact>
    <investigator>
      <last_name>James O'Brien, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southside Hospital / Feinstein Institute for Medical Research</name>
      <address>
        <city>Bayshore</city>
        <state>New York</state>
        <zip>11706</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dalvert Polanco, M.D.</last_name>
      <phone>718-920-6442</phone>
      <phone_ext>8576</phone_ext>
      <email>DAPOLANC@montefiore.org</email>
    </contact>
    <investigator>
      <last_name>Luigi DiBiase, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York University Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Mendelson</last_name>
      <phone>212-263-7704</phone>
      <email>laura.mendelson@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>Anthony Aizer, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital / Icahn School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lissette Rosario-Remigio</last_name>
      <phone>212-824-8909</phone>
      <email>Lissette.Rosario-Remigio@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Vivek Reddy, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keri Baia</last_name>
      <phone>614-685-4621</phone>
      <email>keri.baia@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>John Hummel, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ohio Health Research Institute</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Strausbaugh</last_name>
      <phone>614-566-1253</phone>
      <email>Carol.Strausbaugh@ohiohealth.com</email>
    </contact>
    <investigator>
      <last_name>Sreedhar Billakanty, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southern Oregon Cardiology</name>
      <address>
        <city>Medford</city>
        <state>Oregon</state>
        <zip>97504</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Anne Eisenhaure</last_name>
      <phone>541-930-7253</phone>
      <email>eisenhaurej@socardiology.com</email>
    </contact>
    <investigator>
      <last_name>Eric Pena, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bryn Mawr Medical Specialists Association / Bryn Mawr Hospital</name>
      <address>
        <city>Bryn Mawr</city>
        <state>Pennsylvania</state>
        <zip>19010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Spahr</last_name>
      <phone>215-313-0742</phone>
      <email>judithannspahr@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Sheetal Chandhok, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Herbert, RN, BSN</last_name>
      <phone>412-648-6024</phone>
      <email>herbertsa@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Raveen Bazaz, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29466</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Everidge</last_name>
      <phone>843-792-2944</phone>
      <email>adamsde@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Frank Cuoco, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Meisch</last_name>
      <phone>615-343-4983</phone>
      <email>carol.meisch@Vanderbilt.edu</email>
    </contact>
    <investigator>
      <last_name>Christopher Ellis, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Cardiac Arrhythmia Research Foundation</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deb Cardinal, RN</last_name>
      <phone>512-431-4868</phone>
      <email>dscardinal@austinheartbeat.com</email>
    </contact>
    <investigator>
      <last_name>Rodney Horton, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Austin Heart</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Bacon</last_name>
      <phone>512-421-3877</phone>
      <email>Kevin.Bacon@hcahealthcare.com</email>
    </contact>
    <investigator>
      <last_name>David Tschopp, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor - St. Luke's Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aline Barzilla, CCRC</last_name>
      <phone>832-355-3710</phone>
      <email>abarzilla@bcm.edu</email>
    </contact>
    <investigator>
      <last_name>Abdi Rasekh, MD, F.A.C.C.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center at San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan Drake, RN</last_name>
      <phone>210-567-8692</phone>
      <email>drakep@uthscsa.edu</email>
    </contact>
    <investigator>
      <last_name>Manoj Panday, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Christus Trinity Mother Frances Health System</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Cushman</last_name>
      <phone>903-606-8846</phone>
      <email>Carol.Cushman@tmfhc.org</email>
    </contact>
    <investigator>
      <last_name>Stanley Weiner, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://amazetrial.com/</url>
    <description>aMAZE Trial website</description>
  </link>
  <reference>
    <citation>Lee RJ, Lakkireddy D, Mittal S, Ellis C, Connor JT, Saville BR, Wilber D. Percutaneous alternative to the Maze procedure for the treatment of persistent or long-standing persistent atrial fibrillation (aMAZE trial): Rationale and design. Am Heart J. 2015 Dec;170(6):1184-94. doi: 10.1016/j.ahj.2015.09.019. Epub 2015 Oct 3.</citation>
    <PMID>26678640</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 14, 2017</lastchanged_date>
  <firstreceived_date>July 30, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
